AGTC Partners, L.P.
10% Owner

AGTC Partners, L.P. insider trades: BG Medicine (BGMD) stock buys and sales

10% Owner, BG Medicine Last trade Jul 27, 2015 9 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2011
2
Companies
last trade 2015

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where AGTC Partners, L.P. reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 27, 2015BGMD↓ Sell$11K
Jul 27, 2015BGMD↓ Sell$686
Jan 30, 2013BGMD↑ Buy$2.1M
Jan 30, 2013BGMD↑ Buy$1.0M
Jan 30, 2013BGMD↑ Buy$500K
Jan 30, 2013BGMD↑ Buy$250K
Jan 30, 2013BGMD↑ Buy$150K
Feb 9, 2011BGMD↑ Buy$1.9M
Feb 9, 2011BGMD↑ Buy$100K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About AGTC Partners, L.P.'s insider trades

AGTC Partners, L.P. is a 10% owner of BG Medicine (BGMD). Since Feb 9, 2011, it has reported 7 open-market purchases worth $6.0M and 2 sales worth $12K on SEC Form 4. There have been no open-market trades in the last 12 months.

Its filings also include other transactions (3 filings), grants and awards (3 filings), option exercises (2 filings), conversions (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BGMD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.